ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
for Non Small Cell Lung Cancer
46 locations incl. Dothan
Sponsor: OncoC4, Inc.
Sex: All·Age: 18+
Code: NCT05671510·Phase 3·Recruiting·Listed Jan 2023
XCancer/Dothan Hematology & Oncology - 1114
Clinical research site in Dothan, Alabama
As of July 2026, 1 paid clinical trial is recruiting at XCancer/Dothan Hematology & Oncology - 1114 in Dothan, Alabama. Active studies at this site focus on Non Small Cell Lung Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at XCancer/Dothan Hematology & Oncology - 1114? We'll email you when one opens.
Recruiting clinical trials at XCancer/Dothan Hematology & Oncology - 1114 (1)
Get new-trial alerts for XCancer/Dothan Hematology & Oncology - 1114
We'll email you whenever a new clinical trial starts recruiting at this research site in Dothan, AL. Unsubscribe anytime.
More research sites in Dothan
- SEC Clinical Research (5 trials)
- Trinity Research Group (4 trials)
- Glaukos Investigative Site (3 trials)
- Digestive Health Specialists (3 trials)
- Akero Clinical Study Site (2 trials)
- Digestive Health Specialists of the Southeast (Gastroenterology Associates of Dothan) - Dothan (2 trials)
- Digestive Health Specialsits (2 trials)
- Harmonex Neuroscience Research (2 trials)
- Alkermes Investigational Site (1 trial)
- Alkermes Investigator Site (1 trial)
Explore more
Paid clinical trials in Dothan, AL · Alabama clinical trials